Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Adv Ther (Weinh). 2019 Apr 26;2(7):1900047. doi: 10.1002/adtp.201900047

Figure 6.

Figure 6

GAPDH knockdown in A) Jurkat cells and B) primary CD4+ human T cells after treatment with GAPDH siRNA (siGAPDH; green bars, indicated by polyplex type used for transfection) or scrambled siRNA as negative control (NC). (Data points indicate mean ± SD, n = 3; One-way ANOVA, *p < 0.05; **p < 0.01; ***p < 0.005).